Hinova Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Hinova Pharmaceuticals has a total shareholder equity of CN¥1.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥173.2M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥909.29m |
| Equity | CN¥1.23b |
| Total liabilities | CN¥173.17m |
| Total assets | CN¥1.40b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 688302's short term assets (CN¥956.8M) exceed its short term liabilities (CN¥150.1M).
Long Term Liabilities: 688302's short term assets (CN¥956.8M) exceed its long term liabilities (CN¥23.1M).
Debt to Equity History and Analysis
Debt Level: 688302 is debt free.
Reducing Debt: 688302 currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688302 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 688302 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 20.1% each year